ICER’s Unsupported Price Increase Report: Unfit for Policymaking
Since 2019, the Institute for Clinical and Economic Review (ICER) has published an annual Unsupported…
Certara2023年7月25日
Leveraging Pharmacokinetic Modeling & Scientific Communications Expertise Advances Sarcoidosis Drug Program
Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…
Certara2023年6月1日
Translational Pharmacology Consulting Supports Combination Therapy for Treating Pulmonary Mycobacterium Avium Complex Disease
RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…
Certara2023年5月9日
Using MBMA to run virtual “head-to-head trials”
Osteoporosis is common in post-menopausal women. The long-term sequelae of osteoporosis include bone fractures, particularly…
Certara2023年4月21日
Using Real-World Evidence to Derive an External Control Arm for a Rare Disease Drug Trial
Our client was developing a new anti-viral drug for a rare, life-threatening viral infection that…
Certara2023年4月17日
Using Real World Evidence to Inform Treatment Guidelines
Real-World Evidence (RWE) has become increasingly valuable in informing the development of treatment guidelines for…
Certara2023年4月5日
Using Real Word Evidence to Enhance Drug Development
Real-world evidence (RWE) has emerged as an increasingly important tool in the drug development process,1…
Certara2023年4月5日
Leveraging Clinical Data from One Rare Disease to Support Drug Approval for Another
Atypical hemolytic uremic syndrome (aHUS) is an ultra-rare genetic disease that causes abnormal blood clot…
Certara2022年6月1日
A Bird’s Eye View on Rare Diseases: Key Drug Development Considerations for Thyroid Eye Disease
New therapeutics discovery and development for ocular diseases have been traditionally associated with a low…
Certara2021年12月15日
Dose Optimization Using Population PK for an Orphan Drug
RAPALIMUS® Tablets (sirolimus) is Nobelpharma’s orphan drug developed from an oral medication that is sold…
Certara2021年11月17日
